2010-14317. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Mammography Quality Standards Act Requirements  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

    DATES:

    Fax written comments on the collection of information by July 15, 2010.

    ADDRESSES:

    To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, FAX: 202-395-7285, or e-mailed to oira_submission@omb.eop.gov. All comments should be identified with the OMB control number 0910-0309. Also include the FDA docket number found in brackets in the heading of this document.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-5156, Daniel.Gittleson@fda.hhs.gov.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

    The Mammography Quality Standards Act Requirements—21 CFR Part 900 (OMB Control Number 0910-0309)—Extension

    The Mammography Quality Standards Act requires the establishment of a Federal certification and inspection program for mammography facilities; Start Printed Page 33812regulations and standards for accreditation and certification bodies for mammography facilities; and standards for mammography equipment, personnel, and practices, including quality assurance. The intent of these regulations is to assure safe, reliable, and accurate mammography on a nationwide level. Under the regulations, as a first step in becoming certified, mammography facilities must become accredited by an FDA-approved accreditation body. This requires undergoing a review of their clinical images and providing the accreditation body with information showing that they meet the equipment, personnel, quality assurance and quality control standards, and have a medical reporting and recordkeeping program, a medical outcomes audit program, and a consumer compliant mechanism. On the basis of this accreditation, facilities are then certified by FDA or an FDA approved State certification agency and must prominently display their certificate. These actions are taken to ensure safe, accurate, and reliable mammography on a nationwide basis. The following sections of title 21 of the Code of Federal Regulations (CFR) were not included in the previously mentioned burden tables because they were considered usual and customary practice and were part of the standard of care prior to the implementation of the regulations. Therefore, they resulted in no additional reporting or recordkeeping burden: 21 CFR 900.12(c)(1) and (c)(3) and 21 CFR 900.3(f)(1). Section 900.3(c) was not included in the previously mentioned burden tables because all four existing accreditation bodies are approved until late in 2013; so, no applicants will reapply during the requested information collection period. Section 900.24(c) was also not included in the previously mentioned burden tables because if a certifying state had its approval withdrawn, FDA would take over certifying authority for the affected facilities. Because FDA already has all the certifying state's electronic records, there wouldn't be an additional reporting burden.

    In the Federal Register of March 11, 2010 (75 FR 11542), FDA published a 60-day notice requesting public comment on the proposed collection of information. No comments were received.

    FDA estimates the burden of this collection of information as follows:

    Table 1—Estimated Annual Reporting Burden

    21 CFR SectionNo. of RespondentsAnnual Frequency per ResponseTotal Annual ResponsesHours per ResponseTotal HoursTotal Capital CostsTotal Operating & Maintenance Costs
    900.3(b)(1)0.3310.3310.33
    900.3(b)(3) full10.3310.33320106$10,000
    900.3(b)(3) limited251530150
    900.3(c)31.3311.331520
    900.3(d)(2)0.110.1303
    900.3(d)(5)0.110.1303
    900.3(e)0.110.110.1
    900.3(f)(2)0.110.120020$45
    900.4(c), 900.11(b)(1), and 900.11(b)(2) facility42,89412,8941.54,341
    900.4(c) AB55154212,105$173,620
    900.4(d), 900.11(b)(1), and 900.11(b)(2) facility42,89412,894.752,171
    900.4(d) AB55152111,055
    900.4(e), 900.11(b)(1), and 900.11(b)(2) facility48,68118,68118,681$8,681
    900.4(e) AB55151,7368,680
    Start Printed Page 33813
    900.4(f)331133172,317$77,640
    900.4(h) facility48,68118,68118,681$3,820
    900.4(h) AB55151050
    900.4(i)(2)1111616
    900.6(c)(1)0.110.1606
    900.11(b)(3)515.52.5
    900.11(c)400140052,000
    900.12(c)(2)8,6814,94242,901,502.08333333,575,124$19,500,000
    900.12(c)(2) patient refusal687187.543.5
    900.12(h)(4)71717
    900.12(j)(1) facility48182001,600$120
    900.12(j)(1) AB58183202,560$240
    900.12(j)(2)212100200$3,875
    900.15(c)515210
    900.15(d)(3)(ii)11122
    900.18(c)21224
    900.18(e)21212
    900.21(b)0.3310.33320106$30,000$174
    900.21(c)(2)0.110.1303
    900.22(h)52001,000.08383
    900.22(i)2123060$20
    900.2351520100
    900.24(a)0.410.420080$42
    900.24(a)(2)0.1510.1510015$21
    900.24(b)1113030
    900.24(b)(1)0.310.320060$42
    900.24(b)(3)0.1510.1510015$21
    900.25(a)0.210.2163.2
    FDA Form 34227001700.25175
    Total3,620,692$40,000$19,768,361
    1 One-time burden.
    2 Refers to accreditation bodies applying to accredit specific Full Field Digital Mammography units.
    3 While not included in the 60-day notice, all 4 accreditation bodies are expected to reapply to continue to be accreditation bodies during the information collection period.
    4 Refers to the facility component of the burden for this requirement.
    5 Refers to the accreditation body component of the burden for this requirement.
    6 Refers to the situation where a patient specifically does not want to receive the lay summary of her exam.
    Start Printed Page 33814

    Table 2—Estimated Annual Recordkeeping Burden

    21 CFR SectionNo. of RecordkeepersAnnual Frequency per RecordkeepingTotal Annual RecordsHours per RecordTotal HoursTotal Capital CostsTotal Operating & Maintenance Costs
    900.3(f)(1)0.110.100
    900.4(g)51515
    900.12(a)(1)(i)(B)(2)871878696
    900.12(a)(4)8,681434,724134,724
    900.12(c)(4)8,68118,68118,681$28,000
    900.12(e)(13)8,68152451,412.08333337,618
    900.12(f)8,68118,68116138,896
    900.12(h)(2)8,681217,362117,362
    900.22(a)51515
    900.22(d)51515
    900.22(e)51515
    900.22(f)31313
    900.22(g)51515$50
    900.25(b)51515
    Total238,010$28,000$50
    Start Signature

    Dated: May 27, 2010.

    Leslie Kux,

    Acting Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2010-14317 Filed 6-14-10; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Comments Received:
0 Comments
Published:
06/15/2010
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
2010-14317
Dates:
Fax written comments on the collection of information by July 15, 2010.
Pages:
33811-33814 (4 pages)
Docket Numbers:
Docket No. FDA-2010-N-0121
PDF File:
2010-14317.pdf